Literature DB >> 21041504

New species genetic approach to identify strains of mitis group streptococci that are donors of rifampin resistance to Streptococcus pneumoniae.

María-José Ferrándiz1, Carmen Ardanuy, Josefina Liñares, Luz Balsalobre, María Teresa García, Adela G de la Campa.   

Abstract

Eight rifampin-resistant streptococci of the mitis group were identified at the species level by using a concatenated 16S rRNA gene-sodA-rpoB-hlpA sequence. Characterization of their rpoB alleles showed single amino acid changes involved in rifampin resistance. Comparison of RpoB sequences from pneumococcal recombinant isolates, viridans isolates, and type strains revealed a species-specific amino acid signature, which allowed it to be ascertained that recombinant RpoBs were originated in genetic interchanges with Streptococcus mitis and Streptococcus oralis.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21041504      PMCID： PMC3019657          DOI： 10.1128/AAC.00856-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  37 in total

1.  rpoB mutations in Streptococcus mitis clinical isolates resistant to rifampin.

Authors:  Wafa Achour; Olfa Guenni; Marguerite Fines; Roland Leclercq; Assia Ben Hassen
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

Review 2.  Resistance to antibiotics mediated by target alterations.

Authors:  B G Spratt
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

3.  Bacterial interference. II. Role of the normal throat flora in prevention of colonization by group A Streptococcus.

Authors:  C C Crowe; W E Sanders; S Longley
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

4.  Identity of viridans streptococci isolated from cases of infective endocarditis.

Authors:  C W Douglas; J Heath; K K Hampton; F E Preston
Journal:  J Med Microbiol       Date:  1993-09       Impact factor: 2.472

5.  Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: a randomized placebo-controlled study.

Authors:  K Roos; S E Holm; E Grahn; L Lind
Journal:  Scand J Infect Dis       Date:  1993

6.  Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

Authors:  M M París; S M Hickey; M I Uscher; S Shelton; K D Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

7.  Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.

Authors:  P Y Bochud; P Eggiman; T Calandra; G Van Melle; L Saghafi; P Francioli
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

8.  Viridans streptococci isolated from the bloodstream. Relevance of species identification.

Authors:  J A Jacobs; H C Schouten; E E Stobberingh; P B Soeters
Journal:  Diagn Microbiol Infect Dis       Date:  1995-07       Impact factor: 2.803

9.  Determination of 16S rRNA sequences of Streptococcus mitis and Streptococcus gordonii and phylogenetic relationships among members of the genus Streptococcus.

Authors:  Y Kawamura; X G Hou; F Sultana; H Miura; T Ezaki
Journal:  Int J Syst Bacteriol       Date:  1995-04

10.  Molecular basis of rifampicin resistance in Haemophilus influenzae.

Authors:  Susana Cruchaga; María Pérez-Vázquez; Federico Román; José Campos
Journal:  J Antimicrob Chemother       Date:  2003-11-12       Impact factor: 5.790
View more
  1 in total

Review 1.  Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.

Authors:  Lindsay Kim; Lesley McGee; Sara Tomczyk; Bernard Beall
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.